Multivariate analysis of plasma hormones in patients with metastatic prostate cancer receiving combined LHRH-analog and antiandrogen therapy

The following hormones, the plasma protein SHBG, and the tumor markers prostatic acid phosphatase (PAP) and prostate-specific antigen (PSA) were assayed at 18 time-points over 1 month during a double-blind randomized study in 36 stage D2 cancer patients receiving either "buserelin+placebo"...

Full description

Saved in:

Bibliographic Details
Published in:	The Prostate Vol. 23; no. 4; p. 291
Main Authors:	Fiet, J, Doré, J C, Gô, A L, Ojasoo, T, Raynaud, J P
Format:	Journal Article
Language:	English
Published:	United States 1993
Subjects:	Aged Aged, 80 and over Androgen Antagonists - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers, Tumor - blood Buserelin - administration & dosage Buserelin - therapeutic use Double-Blind Method Hormones - blood Humans Imidazoles - administration & dosage Imidazolidines Male Middle Aged Multivariate Analysis Neoplasm Metastasis Prostatic Neoplasms - blood Prostatic Neoplasms - drug therapy
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!